H.C. Wainwright Lifts PT on Ocular Therapeutix (OCUL) to $19 From $15, Keeps a Buy Rating

新聞報導於1天前

撰寫摘要中...

您可能也對這些小見聞有興趣

Nestlé CEO Philipp Navratil assertive on strategy but can he deliver?

H.C. Wainwright Lifts PT on Ocular Therapeutix (OCUL) to $19 From $15, Keeps a Buy Rating

Citizen JMP Raises PT on Robinhood Markets (HOOD), Keeps a Buy Rating

Projected mortgage interest rates for the next 5 years

AI Startup WellTheory Raises $14 Million From General Catalyst, Accel, 7wire Ventures To Transform Autoimmune Health For Millions Of Patients

Unusually Active Options: 3 Long Strangle Plays to Watch This Weekend

What is a Christmas club account, and should you open one before the holidays?

3 consumer categories likely to dominate 2025 holiday shopping

Lexeo Therapeutics Announces FDA Support for Accelerated Approval Pathway, Positive Interim Data for Gene Therapy LX2006

Salesforce’s Benioff Apologizes for Pro-Trump National Guard Comments

返回所有小見聞